GET DAILY SIGNALSWhy Is Aehr Test Systems (AEHR) Stock Down -18.33% Today?
Key Takeaways
- Aehr Test Systems (AEHR) shares tumbled roughly 18.33% to about $49.69, down from a prior close of $60.84.
- The selloff marks a full round-trip of the post-earnings surge, with the stock now trading below its pre-report close of $51.47.
- The primary catalyst is aggressive profit-taking after a blowout fiscal first-quarter report, compounded by analyst price-target cuts.
- Jefferies trimmed its target to $140 from $175, while Lake Street lowered its target to $90 from $110, citing broader semiconductor capital-equipment multiple compression.
- Elevated valuation and fading AI-sector momentum are adding to downside pressure despite record revenue and raised guidance.
- Traders are watching whether the stock can hold near-term support and whether AI-related capex sentiment stabilizes.
- For deeper insight, explore detailed Price Targets, Earnings data, and Forecast pages.
- Discover the strongest-performing strategies for this and other tickers by exploring Trending AI Robots.
Opening Summary
Aehr Test Systems, Inc. (AEHR), a Fremont, California-based provider of wafer-level and package-level semiconductor test and burn-in systems, is suffering a sharp reversal in Thursday's session. Shares plunged approximately 18.33% to around $49.69, down from the previous session's close of $60.84. The decline unwinds virtually all of the gains triggered by the company's record fiscal first-quarter results, leaving the stock below the $51.47 level at which it closed before the earnings release. Markets attributed the move to heavy post-earnings profit-taking, downward analyst price-target revisions, and a broader cooling in AI-focused semiconductor valuations.
Post-Earnings Profit-Taking and a Full Round-Trip
The selling pressure is best understood as a reversal of an unusually explosive earnings reaction. Aehr reported fiscal first-quarter 2027 results after the close on November 2, delivering record revenue of $33.0 million, up roughly 201% year over year, alongside non-GAAP earnings of $0.28 per share that crushed consensus estimates of roughly $0.10 to $0.11. Management raised its full-year revenue outlook to $150 million, the top of its prior range, and guided to non-GAAP net income of at least 20% of revenue.
Those results sent AEHR surging more than 26% on November 3 to $65.11. However, momentum faded quickly. The stock slipped 6.56% the following day, and Thursday's drop has now erased the entire earnings-driven advance. For a high-beta, relatively small-capitalization name, this kind of round-trip is common after a crowded, single-event rally, as short-term traders lock in gains and momentum reverses.
Analyst Price-Target Cuts
Despite the company's strong results, Wall Street has been recalibrating its valuation assumptions. Jefferies maintained a Buy rating but lowered its price target to $140 from $175, while Lake Street kept its Buy rating and reduced its target to $90 from $110. Both firms acknowledged the strength of the quarter and the raised guidance, but pointed to broader multiple compression across the semiconductor capital-equipment sector as justification for the reductions. Even with these cuts, the consensus target of roughly $127 implies substantial upside, yet the market's near-term reaction has focused on the downward revision rather than the underlying fundamentals.
Sector Momentum and AI-Capex Multiple Compression
The decline is also consistent with a broader rotation out of high-multiple, AI-adjacent semiconductor equipment names. Aehr trades at a premium valuation — roughly 65 to 70 times forward non-GAAP earnings — which leaves little room for error when sentiment toward AI infrastructure spending wavers. As investors reassess the sustainability and pace of AI-related capital expenditures, small-cap equipment suppliers with elevated multiples have borne the brunt of the selling. The stock's high beta and substantial short interest amplify these moves in both directions.
Market Context and Trading Activity
Volume has been notably heavy across the week, reflecting the post-earnings volatility. Aehr's turnover has run well above its longer-term average, consistent with active institutional repositioning and elevated retail participation. Technically, the stock has broken back below its 20-day moving average and is now trading far beneath its 52-week high of $147.40, underscoring the extent of the recent drawdown despite the strong quarterly results. The move diverges from the company's own operating momentum, which remains robust — bookings of $46.7 million produced a book-to-bill ratio near 1.4, and effective backlog reached $109.3 million as of November 1.
What Comes Next for AEHR
Looking ahead, investors will be watching whether Aehr can stabilize after this sharp pullback and whether the company converts its growing backlog into sustained sequential revenue growth. Management has indicated it expects revenue to increase each quarter through the remainder of fiscal 2027, and the recently disclosed progress with major AI-accelerator, silicon photonics, and silicon carbide customers offers a credible growth runway. Key risks include continued multiple compression across the semiconductor equipment space, customer concentration, lumpy order timing, and any further deterioration in AI-capital-expenditure sentiment. Near-term trading is likely to remain volatile given the stock's elevated beta and meaningful short interest.
Trending AI Robots
Tickeron offers hundreds of AI-powered trading bots covering thousands of tickers, but only the strongest performers under current market conditions are featured in its curated Trending AI Robots section. These bots vary by strategy, timeframe, performance metrics, and the symbols they trade, allowing users to identify approaches that align with their own objectives and risk tolerance. Explore the Trending AI Robots page to see which automated strategies are currently leading the market.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
Momentum Indicator for AEHR turns negative, indicating new downward trend
AEHR saw its Momentum Indicator move below the 0 level on November 04, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 84 similar instances where the indicator turned negative. In 72 of the 84 cases, the stock moved further down in the following days. The odds of a decline are at 86%.
Technical Analysis (Indicators)
Bearish Trend Analysis
AEHR moved below its 50-day moving average on October 06, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for AEHR crossed bearishly below the 50-day moving average on October 09, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 12 of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 75%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AEHR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 83%.
The Aroon Indicator for AEHR entered a downward trend on November 04, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where AEHR's RSI Indicator exited the oversold zone, 28 of 32 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 88%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 53 of 56 cases where AEHR's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 90%.
The Moving Average Convergence Divergence (MACD) for AEHR just turned positive on November 03, 2026. Looking at past instances where AEHR's MACD turned positive, the stock continued to rise in 34 of 38 cases over the following month. The odds of a continued upward trend are 89%.
Following a +14.03% 3-day Advance, the price is estimated to grow further. Considering data from situations where AEHR advanced for three days, in 245 of 274 cases, the price rose further within the following month. The odds of a continued upward trend are 89%.
AEHR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 4 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.052) is normal, around the industry mean (6.097). AEHR has a moderately low P/E Ratio (-264.522) as compared to the industry average of (79.345). Projected Growth (PEG Ratio) (0.927) is also within normal values, averaging (0.801). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (51.813) is also within normal values, averaging (27.897).
The Tickeron PE Growth Rating for this company is 22 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 63 (best 1 - 100 worst), indicating steady price growth. AEHR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 69 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AEHR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 76, placing this stock better than average.
The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a manufacturer of burn-in and test equipment for semiconductor manufacturing
Industry ElectronicProductionEquipment
Advertisement